Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States.
By P. Muntner, Jiang He, L. Hamm, C. Loria, P. Whelton. Journal of the American Society of Nephrology, 2002
855 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/5106cb68492dca184604f674e0535eaf75040a92
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- R. Foley
- Anne M. Murray
- Paul Eggers
- Shuling Li
- C. Herzog
- B. Oberg
- A. McBean
- A. Collins
Citations in the corpus
- Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. (2005, background): “Materials and Methods The objectives of this study were to compare patients with and without CKD on the basis of (1) cross-sectional associations with diabetes, age, demographic cardiovascular disease, and other comorbid conditions; (2) incidence of atherosclerotic vascular disease; (3) incidence of”
- Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. (2003, methodology): “The current analysis of the ARIC cohort adds to those studies by having prospective standardized ASCVD event ascertainment (8,15), rather than relying on death certificate data as the primary outcome (6,7).”
- Chronic kidney disease and mortality risk: a systematic review. (2006, unknown): “1 — 47 — 43 4 SCr 122 mol/L M SCr 104 mol/L W NHANES II 2002 (16) P-CS; NHANES II; US General population, age 30 to 74 yr 6453 14.”
- Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. (2004, background): “Several studies in high-risk populations and community-based studies have identified the level of kidney dysfunction as an independent risk factor for cardiovascular outcomes and all-cause mortality [7–13].”
- Renal Insufficiency and Heart Failure: Prognostic and Therapeutic Implications From a Prospective Cohort Study (2004, unknown): “Age, y 64 (14) 51 (12) 63 (11) 73 (10) 78 (11) 0.”